The Series A round was led by Planet A Ventures with participation from Maersk Growth, Pale blue dot and Eka Ventures.
"Our mission at HIVED is to decarbonise the logistics industry while setting a new standard for delivery quality. In an industry that has historically failed customers and the planet, we see the incredible need for HIVED’s solution and are rising to that opportunity, building a parcel delivery service that consumers genuinely enjoy and merchants can trust"
The Series A financing will support the property firm as it scales its gradual homeownership operations and aims to break even.
"Due to the way that the Gradual Homeownership model works, the rising interest rates seen since September’s controversial mini-budget have delivered even greater demand for our product. With the recent ending of the Help to Buy scheme there are now hundreds of thousands of would-be homeowners seeking alternative ways to access the property ladder. This significant raise will fuel our ambitions to double the pace at which we can help new homeowners within 12 months."
The investment round was led by Notion Capital and will fund product development and North American expansion.
"In a more challenging software market, SaaS businesses are balancing growth with profitability, making pricing an ever-more valuable lever. Hybrid and usage-based pricing are now firmly in the spotlight because of their ability to deliver better customer experiences while reducing churn and increasing revenue, and as their popularity continues to grow, the opportunity for m3ter is obvious. Today’s funding enables us to take our ambitions to the next level, making new pricing models accessible for every software business that needs them."
The medical device maker has raised fresh capital from backers including Crimson International Investment to support its global growth plans.
"We are delighted to secure further funding, as well as another strategic investor and partner to take our pioneering Parkinson’s monitoring device into new markets. NICE’s positive evaluation and recommendation, which supports NHS use of PDMonitor, was a big endorsement for our business and technology."
